Rounding@IOWA episode 71: The 'Wild West' of biosimilars

Biologics are complex, high-cost treatments derived from living systems, used for immune-related disorders. Biosimilars are more affordable alternatives that are highly similar to biologics, with no significant clinical differences. The FDA supports biosimilar development to reduce costs, and various financial aids are available to help patients access these treatments. Join us as we discuss these important topics. CME credit available for listening.

2024 Distinguished Alumni Award for Early Career Achievement: Amber K. Brooks, MD

Amber Brooks’ career is guided by two passions: serving patients living with chronic and complex pain and advocating for compassionate, quality care for all. She is an associate professor of anesthesiology at Wake Forest University School of Medicine and the department’s vice chair of justice, equity, diversity, and inclusion. Through her clinical research, she has cast light on bias and stigma in pain medicine and the healing power of movement. Brooks has led efforts to build health equity into the curriculum for medical learners, and her next goal is to create a training program to boost innovation in the field of addiction medicine through modern data science methods. As of August, she now serves as vice dean for strategic initiatives.

2024 Distinguished Alumni Award for Service: Barbara L. McAneny, MD, MACP, FASCO

Barbara McAneny’s dedication to health advocacy is the cornerstone of her career. Elected President of the American Medical Association in 2017, she focused her tenure on empowering patients and providers alike as she worked to resist large health corporation mergers. As she created the New Mexico Cancer Center, she founded the New Mexico Cancer Center Foundation, which has lifted the burden of non-medical expenses for underserved patients undergoing treatment for serious illness for more than 20 years. She also led oncology practices across the U.S. to create efficiencies in health care delivery that reduce unnecessary hospitalizations with a $19.5 million award from the Centers for Medicare & Medicaid Services. Through all her leadership roles, she has been a champion for affordable, accessible health care for all.